Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Heatwurx Inc. (PCSA : NSDQ)

• Company Description    Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States. Number of Employees: 10

• Price / Volume Information    Yesterday's Closing Price: $0.23 Daily Weekly Monthly 20 Day Moving Average: 47,654,964 shares Shares Outstanding: 11.88 (millions) Market Capitalization: $2.73 (millions) Beta: 1.30 52 Week High: $3.10 52 Week Low: $0.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -33.23% -35.73% 12 Week 4.50% -12.10% Year To Date -73.99% -75.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7380 COCA COLA DRIVE SUITE 106 - HANOVER,MD 21076 USA ph: 443-776-3133 fax: 443-288-4420 ir@processapharma.com http://www.processapharmaceuticals.com

• General Corporate Information    Officers George Ng - Chief Executive Officer Russell Skibsted - Chief Financial Officer Khoso Baluch - Director James Neal - Director Geraldine Pannu - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 74275C304 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/12/25 Share - Related Items Shares Outstanding: 11.88 Most Recent Split Date: 1.00 (0.05:1) Beta: 1.30 Market Capitalization: $2.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.54 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.34 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 72.97% vs. Previous Quarter: 59.46% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -319.56 12/31/24 - -233.22 ROA 06/30/25 - - 03/31/25 - -232.40 12/31/24 - -184.31 Current Ratio 06/30/25 - - 03/31/25 - 2.93 12/31/24 - 1.22 Quick Ratio 06/30/25 - - 03/31/25 - 2.93 12/31/24 - 1.22 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.67 12/31/24 - 0.46 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©